Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'

被引：1
|
作者：
Pethoe-Schramm, Attila [1 ]
Devenport, Jenny [2 ]
Reiss, William [3 ]
机构：
[1] F Hoffmann La Roche & Cie AG, Prod Dev Med Affairs, Basel, Switzerland
[2] F Hoffmann La Roche & Cie AG, Prod Dev Biostat, Basel, Switzerland
[3] Genentech Inc, US Med Affairs, San Francisco, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 08期
关键词：
arthritis; rheumatoid; antirheumatic agents; biological therapy;
D O I：
10.1136/annrheumdis-2020-218365
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab
    Shafran, Inbal Haya
    Alasti, Farideh
    Smolen, Josef S.
    Aletaha, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 874 - 882
  • [2] Response to: 'Comment on 'Implication of baseline levels and early changes of C-reactive protein for subsequent clinical outcomes of patients with rheumatoid arthritis treated with tocilizumab'' by Pethoe-Schramm et al
    Shafran, Inbal Haya
    Alasti, Farideh
    Smolen, Josef S.
    Aletaha, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [3] Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis
    Wang, Jianmei
    Devenport, Jenny
    Low, Jason M.
    Yu, Dale
    Hitraya, Elena
    ARTHRITIS CARE & RESEARCH, 2016, 68 (06) : 882 - 885
  • [4] Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis
    Kojima, Toshihisa
    Yabe, Yuichiro
    Kaneko, Atsushi
    Hirano, Yuji
    Ishikawa, Hisato
    Hayashi, Masatoshi
    Miyake, Hiroyuki
    Takagi, Hideki
    Kato, Takefumi
    Terabe, Kenya
    Wanatabe, Tsuyoshi
    Tsuchiya, Hiroki
    Kida, Daihei
    Shioura, Tomone
    Funahashi, Koji
    Kato, Daizo
    Matsubara, Hiroyuki
    Takahashi, Nobunori
    Hattori, Yosuke
    Asai, Nobuyuki
    Ishiguro, Naoki
    MODERN RHEUMATOLOGY, 2013, 23 (05) : 977 - 985
  • [5] Sarilumab and Tocilizumab Receptor Occupancy (RO), and Effects on C-Reactive Protein (CRP) Levels, in Patients with Rheumatoid Arthritis (RA)
    Xu, Christine
    Nolain, Patrick
    Lu, Qiang
    Paccaly, Anne
    Iglesias-Rodriguez, Melitza
    St John, Gregory
    Nivens, Chad
    Maldonado, Rafael
    Ishii, Tomonori
    Choy, Ernest
    Kanamaluru, Vanaja
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Association Of Mean Changes In Laboratory Safety Parameters With C-Reactive Protein At Baseline and Week 12 In Rheumatoid Arthritis Patients Treated With Tofacitinib
    Strand, V.
    Isaacs, J. D.
    Menon, S.
    Beal, J.
    Nduaka, C. I.
    Krishnaswami, S.
    Riese, R.
    Boy, M. G.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S995 - S996
  • [7] ASSOCIATION OF MEAN CHANGES IN LABORATORY SAFETY PARAMETERS WITH C-REACTIVE PROTEIN AT BASELINE AND WEEK 12 IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB
    Strand, V.
    Isaacs, J.
    Beal, J.
    Nduaka, C.
    Krishnaswami, S.
    Riese, R.
    Boy, M.
    Menon, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 229 - 229
  • [8] SARILUMAB AND TOCILIZUMAB RECEPTOR OCCUPANCY (RO), AND EFFECTS ON C-REACTIVE PROTEIN (CRP) LEVELS, IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Xu, Christine
    Nolain, Patrick
    Lu, Qiang
    Paccaly, Anne
    Iglesias-Rodriguez, Melitza
    St John, Gregory
    Nivens, Chad
    Maldonado, Rafael
    Ishii, Tomonori
    Choy, Ernest
    Kanamaluru, Vanaja
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 719 - 720
  • [9] POST-TREATMENT CHANGES IN SERUM C-REACTIVE PROTEIN LEVELS AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS
    Emery, Paul
    Matteson, E. L.
    Genovese, M.
    Sague, S.
    Hsia, E. C.
    Doyle, M. K.
    Fan, H.
    Elashoff, M.
    Rahman, M. U.
    RHEUMATOLOGY, 2011, 50 : 113 - 114
  • [10] EFFICACY OF TOFACITINIB IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS BY BASELINE C-REACTIVE PROTEIN LEVELS AND ERYTHROCYTE SEDIMENTATION RATES
    Schwartzman, S.
    van Vollenhoven, R.
    Matsumoto, A.
    Orange, D.
    Shah, S.
    DeMasi, R.
    Fan, H.
    Dahl, P.
    Wouters, A.
    Keystone, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 918 - 918
12345